Smith Nicholas Conrad
- SEC CIK
- 0002009130
No open-market purchases or sales filed in the past year.
Current role at each company
- ANRO Alto Neuroscience, Inc.CHIEF FINANCIAL OFFICER & CBOas of Mar 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith Nicholas Conrad as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 (view filing) | Mar 28 | 4 days | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | PPurchase | +6.15K | $16.36 | +$100.6K | +29.7%26.9K after | 2 lots |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | PPurchase | +1.56K | $16.00 | +$25.0K | New position1.56K after |